Dravite Therapeutics, Inc.

New Filing
CIK: 0002133272·Other·DELAWARE·Filed: Jun 24, 2026
Total Offering

$14,983,333

Amount Sold

$14,983,333

Investors

8

First Sale

Apr 20, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
JOSEPH SUM
SANDEEP KULKARNI
BARBARA KOSACZ
MICHAEL MOORE

Company

Dravite Therapeutics, Inc.

401 CAMBRIDGE STREET

SAN FRANCISCO, CA, 94134

650-269-3210

SEC Filing

0001231919-26-000695

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free